Qihan Biotech Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
79
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$13.7M
- Investors
-
12
Qihan Biotech General Information
Description
Developer of biotechnological products designed for immune-privileged cell and organ therapies. The company's technology utilises multiplexable genome editing and immune shielding to produce immune-privileged cells and organs, providing healthcare providers with allogeneic and xenogeneic transplantation options to address organ shortages and treat medical conditions.
Contact Information
Website
www.qihanbio.comCorporate Office
- 5th Floor, Building B, Transfar Science and Technology Innovation Building
- Xiaoshan Science and Technology City, Xiaoshan District
- Hangzhou, Zhejiang 311200
- China
Corporate Office
- 5th Floor, Building B, Transfar Science and Technology Innovation Building
- Xiaoshan Science and Technology City, Xiaoshan District
- Hangzhou, Zhejiang 311200
- China
Qihan Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 22-Sep-2023 | $13.7M | Completed | Generating Revenue | ||
| 3. Early Stage VC (Series A2) | 29-Mar-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A1) | 23-Sep-2019 | $25.5M | $33.3M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 23-Jul-2018 | $7.8M | $7.8M | Completed | Generating Revenue |
Qihan Biotech Comparisons
Industry
Financing
Details
Qihan Biotech Competitors (27)
One of Qihan Biotech’s 27 competitors is MiNA Therapeutics, a Venture Capital-Backed company based in London, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| MiNA Therapeutics | Venture Capital-Backed | London, United Kingdom | ||||
| Cellaion | Formerly VC-backed | Mont-Saint-Guibert, Belgium | ||||
| StemiRNA Therapeutics | Venture Capital-Backed | Shanghai, China | ||||
| Sernova Biotherapeutics | Corporation | Mississauga, Canada | ||||
| Sangamo Therapeutics | Formerly VC-backed | Richmond, CA |
Qihan Biotech Patents
Qihan Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024199244-A1 | Systems and methods for enhanced cell therapies | Inactive | 27-Mar-2023 | ||
| WO-2023147776-A1 | Systems and methods for enhanced immunotherapies | Inactive | 07-Feb-2022 | ||
| WO-2023147777-A1 | Systems and methods for enhanced immunotherapies | Inactive | 07-Feb-2022 | ||
| WO-2023143475-A1 | Methods and compositions for cell-based immunotherapies | Inactive | 28-Jan-2022 | ||
| WO-2023093763-A1 | Systems and methods for cell-based immunotherapies cross-reference | Inactive | 24-Nov-2021 | C07K16/2887 |
Qihan Biotech Signals
Qihan Biotech Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Zhejiang Provincial Financial Holdings | Government | Minority | ||
| LAV (Lilly Asia Fund) | Corporate Venture Capital | Minority | ||
| MPC (Beijing) | Venture Capital | Minority | ||
| BC Global Asset Management | Asset Manager | Minority | ||
| CMB International Capital | Asset Manager | Minority |
Qihan Biotech FAQs
-
When was Qihan Biotech founded?
Qihan Biotech was founded in 2017.
-
Where is Qihan Biotech headquartered?
Qihan Biotech is headquartered in Hangzhou, China.
-
What is the size of Qihan Biotech?
Qihan Biotech has 79 total employees.
-
What industry is Qihan Biotech in?
Qihan Biotech’s primary industry is Biotechnology.
-
Is Qihan Biotech a private or public company?
Qihan Biotech is a Private company.
-
What is Qihan Biotech’s current revenue?
The current revenue for Qihan Biotech is .
-
How much funding has Qihan Biotech raised over time?
Qihan Biotech has raised $114M.
-
Who are Qihan Biotech’s investors?
Zhejiang Provincial Financial Holdings, LAV (Lilly Asia Fund), MPC (Beijing), BC Global Asset Management, and CMB International Capital are 5 of 12 investors who have invested in Qihan Biotech.
-
Who are Qihan Biotech’s competitors?
MiNA Therapeutics, Cellaion, StemiRNA Therapeutics, Sernova Biotherapeutics, and Sangamo Therapeutics are some of the 27 competitors of Qihan Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process